Research & Development
Promega's OncoMate MSI system cleared by FDA
With the FDA clearance, the company said oncologists and pathologists in the U.S. can now access the IVD test that screens for Lynch syndrome in patients with colorectal cancer.
July 29, 2021
Endometrial cancer patients may benefit from multigene testing
The data are strong enough to support routine testing, researchers reported at the meeting, which is being held in a virtual format from June 4-8.
June 6, 2021
Healthy Nevada Project: Community genetic testing needed
The study, conducted by researchers from the Healthy Nevada Project, focused on identifying carriers of hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia.
July 28, 2020
NCCN revamps guidelines on colon cancer genetic testing
The NCCN published its "Genetic/Familial High-Risk Assessment: Colorectal" oncology clinical practice guidelines on July 21, in a move the organization said was aimed at making the guidance reflective of new technologies and more intuitive for healthcare providers. Guidelines are available with free registration on the NCCN website.
July 23, 2020
RNA testing clarifies the unknown in Ambry cancer study
Earlier this month, the company announced the launch of its +RNAinsight paired testing for RNA and DNA for genes associated with hereditary cancers. The idea is that testing for both provides more information for determining cancer risk.
October 24, 2019
Invitae provides free testing to pancreatic cancer patients
Patients must meet criteria in specific clinical areas where genetic testing is underutilized to be eligible for testing. Professional guidelines recommend genetic testing for all pancreatic cancer patients to guide treatment choices and evaluate eligibility for clinical trials, the company noted in a statement.
September 8, 2019
DNA forensic evidence frees Ohio man of rape, attempted rape
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Week in Review: Elizabeth Holmes sentenced; good cholesterol worse for some adults; earlier type 2 diabetes diagnosis; and more
Page 1 of 1